Annual Drug Patent Expirations for GVOKE+HYPOPEN
Gvoke Hypopen is a drug marketed by Xeris and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
GVOKE HYPOPEN drug price trends.
This drug has eighteen patent family members in thirteen countries.
The generic ingredient in GVOKE HYPOPEN is glucagon. One supplier is listed for this compound. Additional details are available on the glucagon profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for XERIS drug GVOKE HYPOPEN